Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells

BACKGROUND: Despite the progress made in the clinical management of metastatic melanoma, a patient’s response to treatment cannot be fully predicted, and intrinsic or acquired resistance that is developed in most melanoma patients warrants further research efforts. In addition to genetic factors, mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Osrodek, Marta, Rozanski, Michal, Czyz, Malgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501594/
https://www.ncbi.nlm.nih.gov/pubmed/32982400
http://dx.doi.org/10.2147/CMAR.S263767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501594/
https://www.ncbi.nlm.nih.gov/pubmed/32982400
http://dx.doi.org/10.2147/CMAR.S263767

Ejemplares similares